• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Orbit International Corp. - Product Image

Orbit International Corp.

  • ID: 622091
  • October 2014
  • Region: Global
  • 56 Pages
  • Wright Investors Service

A textual analysis of the financial results for Orbit International Corp. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Orbit International Corp. There is a textual review of the financial results of Orbit International Corp. versus LGL Group, Inc. (The), Elecsys Corporation and Emrise Corporation. The comparative analysis of these companies compares Sales (sales, sales READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

United States

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Espey Mfg. & Electronics Corp. - Product Thumbnail Image

    Espey Mfg. & Electronics Corp.

    • Language: English
    • 55 Pages
    • Published: February 2015
    FROM
  • Elecsys Corporation - Product Thumbnail Image

    Elecsys Corporation

    • Language: English
    • 55 Pages
    • Published: December 2014
  • LGL Group Inc - Product Thumbnail Image

    LGL Group Inc

    • Language: English
    • 56 Pages
    • Published: January 2015
  • Jaguar Mining Incorporated - Product Thumbnail Image

    Jaguar Mining Incorporated

    • Language: English
    • 55 Pages
    • Published: February 2015
    FROM
  • Dundee Precious Metals Inc. - Product Thumbnail Image

    Dundee Precious Metals Inc.

    • Language: English
    • 55 Pages
    • Published: January 2015
  • Orbit Corporation Limited - Product Thumbnail Image

    Orbit Corporation Limited

    • Language: English
    • 56 Pages
    • Published: January 2015
  • Emrise Corporation - Product Thumbnail Image

    Emrise Corporation

    • Language: English
    • 56 Pages
    • Published: January 2015
  • Orbit Communications - Product Thumbnail Image

    Orbit Communications

    • Language: English
    • 55 Pages
    • Published: February 2015
  • Orbit Exports Limited. - Product Thumbnail Image

    Orbit Exports Limited.

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • Orbit Garant Drilling Incorporated - Product Thumbnail Image

    Orbit Garant Drilling Incorporated

    • Language: English
    • 53 Pages
    • Published: February 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.